Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Arcutis, Ardelyx, Auron, BMS, Celltrion, Gilead, Glaukos, Indivior, Innovent, Insmed, Invivyd, Opus, Porosome, Pyxis, Regeneron, Takeda, Telix, Teva.